Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gaul

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of the American Chemical Society|June 6, 2003
The total synthesis of (+)-migrastatinChristoph Gaul, Jon T Njardarson, Samuel J Danishefsky
The Journal of Organic Chemistry|June 11, 2002
Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacementsAndreas Reichelt, Christoph Gaul, Robin R Frey, et al.
Journal of the American Chemical Society|January 30, 2004
Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatinJón T Njardarson, Christoph Gaul, Dandan Shan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in miceDandan Shan, Lin Chen, Jon T Njardarson, et al.
Tetrahedron Letters|August 3, 2010
Confirmation of the Structures of Synthetic Derivatives of Migrastatin in the Light of Recently Disclosed Crystallographically Based ClaimsPavel Nagorny, Isaac Krauss, Jón T Njardarson, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding PocketClemens Scheufler, Henrik Möbitz, Christoph Gaul, et al.
Journal of the American Chemical Society|September 10, 2004
The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesisChristoph Gaul, Jón T Njardarson, Dandan Shan, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
New Potent DOT1L Inhibitors for <i>in Vivo</i> Evaluation in MouseFrédéric Stauffer, Andreas Weiss, Clemens Scheufler, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
Medchemcomm|August 16, 2018
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge regionRobin A Fairhurst, Thomas Knoepfel, Catherine Leblanc, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American Chemical Society|June 6, 2003
The total synthesis of (+)-migrastatinChristoph Gaul, Jon T Njardarson, Samuel J Danishefsky
The Journal of Organic Chemistry|June 11, 2002
Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacementsAndreas Reichelt, Christoph Gaul, Robin R Frey, et al.
Journal of the American Chemical Society|January 30, 2004
Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatinJón T Njardarson, Christoph Gaul, Dandan Shan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in miceDandan Shan, Lin Chen, Jon T Njardarson, et al.
Tetrahedron Letters|August 3, 2010
Confirmation of the Structures of Synthetic Derivatives of Migrastatin in the Light of Recently Disclosed Crystallographically Based ClaimsPavel Nagorny, Isaac Krauss, Jón T Njardarson, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding PocketClemens Scheufler, Henrik Möbitz, Christoph Gaul, et al.
Journal of the American Chemical Society|September 10, 2004
The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesisChristoph Gaul, Jón T Njardarson, Dandan Shan, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
New Potent DOT1L Inhibitors for <i>in Vivo</i> Evaluation in MouseFrédéric Stauffer, Andreas Weiss, Clemens Scheufler, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
Medchemcomm|August 16, 2018
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge regionRobin A Fairhurst, Thomas Knoepfel, Catherine Leblanc, et al.
Pageof 3